A linear dose-dependent analysis showed that each daily consumption of 12 g of alcohol increased the risks for cirrhosis and hepatocellular carcinoma by 6.2% and 11.5%, respectively. HealthDay News — ...

HealthDay News — For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according to a review published online ...

8 Altogether, the immune-tolerating ability of MTX and assessment of the optimal dose should be investigated further and the results of our present study are promising for the optimisation of ...

As the name implies, the equation estimates four parameters, fitting the data to a sigmoidal (S shaped) curve. The equation for the model is The powered term in the denominator of the equation ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) — For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according ...

The full results of the Phase 1 trial will be presented at the AAAAI/WAO Joint Congress on Sunday, March 2, 2025. Meanwhile, Third Harmonic Bio plans to proceed with THB335 development activities ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

A guide to our carefully selected picks for the top CBD oils for dogs in 2025 to soothe anxiety, pain and arthritis.

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

Opthea's lead compound, sozinibercept, targets VEGF-C/D and is in Phase 3 trials for wet AMD. Read more to see why I'm ...

We used MC simulations of electron tracks for fitting certain parameters of this model, and we used the completed model to predict the influence of intertrack interactions in an irradiated target as a ...